Alternative to Chemo

Chemotherapy focuses on the type of cancer rather than the individual. But no two cancers are alike, so why treat them as if they are?

Breakthroughs in Genomics

We incorporate tumor profiling data, such as next-generation sequencing, to identify the unique nature of your tumor.

Personalized Medicine

We personalize the most advanced treatment options for you, including immunotherapy, targeted therapy, hormone therapy, and recently approved cancer drugs.

Combination Therapy

We make it possible to use combinations of drugs to target multiple cancer mutations at the same time. This is the future of cancer treatment – Now.

Cancer-Related Genes
Cancer-Related Coding Mutations
FDA-Approved Cancer Drugs
Three-Drug Combinations


Customized Just for You

CureMatch uses computation and expertise in oncology, genetics, proteomics, biochemistry, and cell biology to make sense of molecular profiling data, available treatment options, and drug-drug interactions to provide a simple report that ranks the combination therapies that are most likely to be successful.

Personalized Combination Therapy™


Your Tumor DNA is Sequenced

Your doctor takes a biopsy of your tumor and sends the sample for sequencing to understand which mutations your tumor has. Sequencing is performed by a 3rd party service provider.

We Perform a Genetic Analysis


CureMatch uses its software platform to analyze your genetic information and compare it with our large database of information from other patients, clinical trials, and published data.

We Rank the Best Options for You

Factoring in millions of drug combinations and cancer treatment results, CureMatch generates a report for your oncologist ranking the best Personalized Combination Therapy™ options for you.

Your Cancer Treatment Begins

Your oncologist reviews the information and recommends a treatment plan. You and your oncologist begin cancer treatment, using the latest technologies available today.

Making Sense of Precision Medicine Test Results

To learn more about CureMatch’s approach to Personalized Combination Therapy™, watch this web interview with Dr. Razelle Kurzrock, CureMatch Co-Founder and UC San Diego oncologist, and Patient Power Host Andrew Schorr, a two-time cancer survivor.

In the interview, Dr. Kurzrock describes the current limitations of cancer care, how supercomputing and genomics can be used to treat cancer today, and what patients can do to understand the complex genomic data.

CureMatch Co-Founder, Dr. Razelle Kurzrock discusses Precision Medicine and Combination Therapy with Patient Power’s Andrew Schorr.

Used with permission. For more educational videos for families affected by cancer visit